T cell-mediated microglial activation triggers myelin pathology in a mouse model of amyloidosis
- Nat Neurosci. 2024 Jun 27. doi: 10.1038/s41593-024-01682-8.
- 1. Institute of Neuronal Cell Biology, Technical University Munich, Munich, Germany.
- 2. German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.
- 3. Institute for Stroke and Dementia Research, University Hospital of Munich, LMU Munich, Munich, Germany.
- 4. Department of Neurodegenerative Diseases and Geriatric Psychiatry, University Hospital Bonn, Bonn, Germany.
- 5. Department of Neuropathology, University Medical Center Göttingen, Göttingen, Germany.
- 6. Munich Cluster of Systems Neurology (SyNergy), Munich, Germany.
- 7. German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.
- 8. Institute of Neuronal Cell Biology, Technical University Munich, Munich, Germany. [email protected].
- 9. German Center for Neurodegenerative Diseases (DZNE), Munich, Germany. [email protected].
- 10. Institute for Stroke and Dementia Research, University Hospital of Munich, LMU Munich, Munich, Germany. [email protected].
- 11. Munich Cluster of Systems Neurology (SyNergy), Munich, Germany. [email protected].
- # Contributed equally.
Age-related myelin damage induces inflammatory responses, yet its involvement in Alzheimer's disease remains uncertain, despite age being a major risk factor. Using a mouse model of Alzheimer's disease, we found that amyloidosis itself triggers age-related oligodendrocyte and myelin damage. Mechanistically, CD8+ T cells promote the progressive accumulation of abnormally interferon-activated microglia that display myelin-damaging activity. Thus, our data suggest that immune responses against myelinating oligodendrocytes may contribute to neurodegenerative diseases with amyloidosis.
-
Cat. No.Product NameDescriptionTargetResearch Area
-
target: c-FmsResearch Areas: Neurological Disease